	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	07/08/2021
	www.isa.gov.il			www.tase.co.il				Reference:	2021-02-062371	Time of broadcast: 21:14 21:14

Other Report or Announcement

Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

Form 4

ORAMEDPHARMINC_Form4_20210806_isa.pdf


References of previous documents relating to this matter(the reference does not constitute incorporation by reference):



Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 15/06/2021
Address: Avenue of the Americas 01185 , New York 10036 New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: office@oramed.com Company site: www.oramed.com

Previous names of reporting entity:

Name of the Signatory: SILBERMAN DAVID JOSEPH BENJAMIN Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company:
Address: Mamila 20 , Jerusalem 9414409 Telephone: 02-5788763 Facsimile: - E-mail: david@oramed.com 2
USA